Autologous haematopoietic stem cell transplantation (AHSCT) in autoimmune disease adult patients in France: analysis of the long-term outcome from the French Society for Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)
ConclusionsThis first SFGM-TC retrospective report shows long-term benefit of AHSCT in AD patients with acceptable toxicity.
Source: Clinical Rheumatology - Category: Rheumatology Source Type: research
More News: Autoimmune Disease | Bone Marrow Transplant | Brain | France Health | Multiple Sclerosis | Neurology | Rheumatology | Scleroderma | Stem Cell Therapy | Stem Cells | Study | Toxicology | Transplants